Phenotypic characterization of bladder cancer

Eur Urol. 1998:33 Suppl 4:5-6. doi: 10.1159/000052250.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / analysis*
  • Antigens, Neoplasm / analysis*
  • Antigens, Neoplasm / drug effects
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Biomarkers, Tumor / analysis*
  • Carcinoma, Transitional Cell / drug therapy
  • Carcinoma, Transitional Cell / pathology*
  • Carcinoma, Transitional Cell / secondary
  • Cisplatin / administration & dosage
  • Disease Progression
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Immunotherapy
  • Lymphatic Metastasis
  • Male
  • Mass Screening / methods
  • Methotrexate / administration & dosage
  • Microscopy, Electron
  • Neoplasm Staging
  • Phenotype
  • Prognosis
  • Sensitivity and Specificity
  • Urinary Bladder Neoplasms / drug therapy
  • Urinary Bladder Neoplasms / pathology*
  • Vinblastine / administration & dosage

Substances

  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Vinblastine
  • Doxorubicin
  • Cisplatin
  • Methotrexate

Supplementary concepts

  • M-VAC protocol